Stock GWII GOOD WORKS II ACQUISITION CORP.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Good Works II Acquisition Corp.

Equities

GWII

US38216G1040

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Good Works II Acquisition Corp.(NasdaqCM:GWII) dropped from NASDAQ Composite Index
CI
Good Works II Acquisition : Other Event - Form 8-K
PU
GOOD WORKS II ACQUISITION CORP. : Other Events (form 8-K)
AQ
GOOD WORKS II ACQUISITION CORP. : Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
AQ
Direct Biologics LLC cancelled the acquisition of Good Works II Acquisition Corp. from I-B Good Works 2, LLC and others in a reverse merger transaction.
CI
GOOD WORKS II ACQUISITION CORP. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)
AQ
GOOD WORKS II ACQUISITION CORP. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
GOOD WORKS II ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
Good Works II Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Good Works II Acquisition, Direct Biologics Enter SPAC Merger Deal
MT
Direct Biologics to list in U.S. via $1 billion SPAC
RE
Good Works II Acquisition Corp. and Direct Biologics, LLC Announce a Definitive Agreement for a Business Combination
BU
GOOD WORKS II ACQUISITION CORP. : Entry into a Material Definitive Agreement, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
Good Works II Acquisition Signs Letter of Intent for Business Combination With Direct Biologics
MT
Good Works II Acquisition Corp. Announces Letter of Intent for a Business Combination with Direct Biologics, LLC
BU
GOOD WORKS II ACQUISITION CORP. : Other Events, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
Direct Biologics LLC announced that it expects to receive $100 million in funding from IB Investments 1 LLC, and other investors
CI
Direct Biologics LLC entered into a non-binding letter of intent to acquire Good Works II Acquisition Corp. from I-B Good Works 2, LLC and others for approximately $630 million in a reverse merger transaction.
CI
GOOD WORKS II ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
Good Works II Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GWII Stock
  4. News Good Works II Acquisition Corp.